![LAVA Therapeutics NV](/common/images/company/N_LVTX.png)
LAVA Therapeutics NV (LVTX)
NASDAQ
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Total Revenue | 468k | 15.26M | 2.64M | 1.22M | 5.14M | 53k | 353k | 6.99M |
Operating Income | -11.08M | -4.71M | -11.56M | -13.54M | -13.55M | -18.31M | -15.89M | -1.95M |
Pre Tax Income | -8.03M | 1.06M | -14.93M | -13.87M | -12.6M | -8.79M | -6.44M | -484k |
Net Income | -8.11M | 1.02M | -15M | -13.94M | -12.7M | -8.84M | -6.5M | -553k |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -11.08M | -4.71M | -11.56M | -13.54M | -13.55M | -18.31M | -15.89M | -1.95M |
EBITDA | -10.8M | -5.05M | -10.78M | -13.23M | -13.25M | -18.43M | -15.1M | -1.71M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 3.5M | 5.35M | 19.39M | 6.77M |
Operating Income | -9.58M | -14.92M | -43.61M | -34.84M | -43.25M |
Pre Tax Income | -9.69M | -15.46M | -42.2M | -31.66M | -41.7M |
Net Income | -9.69M | -15.51M | -42.36M | -31.91M | -41.97M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.287 | -0.571 | -0.549 | -0.411 | -0.537 |
EBIT | -9.58M | -14.92M | -43.61M | -34.84M | -43.25M |
EBITDA | -9.32M | -14.46M | -43.06M | -34.06M | -41.98M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.